A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck
<p>Abstract</p> <p>Background</p> <p>Former meta-analyses have shown a survival benefit for the addition of chemotherapy (CHX) to radiotherapy (RT) and to some extent also for the use of hyperfractionated radiation therapy (HFRT) and accelerated radiation therapy (AFRT)...
Main Authors: | Budach V, Hehr T, Budach W, Belka C, Dietz K |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-01-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/6/28 |
Similar Items
-
A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas
by: Felix Roland, et al.
Published: (2006-02-01) -
Accelerated Hyperfractionated Radiotherapy versus Conventional Fractionation Radiotherapy for Head and Neck Cancer: A Meta-Analysis of Randomized Controlled Trials
by: Bo Zhu, et al.
Published: (2019-01-01) -
Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma
by: Dirk Van Gestel, et al.
Published: (2020-03-01) -
A Randomized Prospective Study of Concurrent Chemo-Radiotherapy vs Accelerated Hyperfractionation in Advanced Cancer of Head and Neck
by: Himanshu Mishra, et al.
Published: (2016-10-01) -
Accelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trials
by: Liu YY, et al.
Published: (2017-06-01)